-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Fusion Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q1 2024.
- Fusion Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 83.8M shares, a 55.8% increase year-over-year.
- Fusion Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 65.6M shares, a 50% increase from 2022.
- Fusion Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 43.7M shares, a 2.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)